Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D₃, 1,25-Dihydroxyvitamin D₃ and 24R,25-Dihydroxyvitamin D₃

• Karen van der Meijden,

  Affiliation Department of Internal Medicine/Endocrinology, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands

  ⨯
• Paul Lips,

  Affiliation Department of Internal Medicine/Endocrinology, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands

  ⨯
• Marjolein van Driel,

  Affiliation Department of Internal Medicine/Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands

  ⨯
• Annemieke C. Heijboer,

  Affiliation Department of Clinical Chemistry, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands

  ⨯
• Engelbert A. J. M. Schulten,

  Affiliation Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center, Academic Centre for Dentistry Amsterdam, Amsterdam, The Netherlands

  ⨯
• Martin den Heijer,

  Affiliation Department of Internal Medicine/Endocrinology, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands

  ⨯
• Nathalie Bravenboer

  * E-mail: n.bravenboer@vumc.nl

  Affiliation Department of Clinical Chemistry, VU University Medical Center, Research Institute MOVE, Amsterdam, The Netherlands

  ⨯